Clik here to view.
CryoLife in $130m deal to enter valve market with On-X Life Technologies buy
CryoLife Inc. (NYSE:CRY) made a big play yesterday for the mechanical heart valve space with a $130 million deal to buy On-X Life Technologies. On-X makes an aortic valve replacement and is developing...
View ArticleClik here to view.
OrbiMed launches $950m healthcare fund
OrbiMed said it closed another venture capital fund worth $950 million that it plans to deploy on about 30 companies in the medical device, biopharmaceutical, diagnostics and healthcare IT markets. The...
View ArticleClik here to view.
Intuitive Surgical puts another $9 million into Luna Innovations’...
Luna Innovations (NSDQ:LUNA) said today that Intuitive Surgical (NSDQ:ISRG) agreed to put up another $9 million for the shape-sensing technology it bought for its da Vinci robot-assisted surgery...
View ArticleClik here to view.
EnteroMedics pulls trigger on 1-for-15 reverse split
EnteroMedics (NSDQ:ETRM) said today its board authorized a 1-for-15 reverse stock split, effective on January 7 next year. As a result of the split, every 15 shares of stock in the St. Paul,...
View ArticleClik here to view.
Titan Medical closes in on 1st-in-human for Sport surgical robot
Titan Medical (CVE:TMD) said this week that initial versions of its Sport robot-assisted surgery platform are ready for engineering verification ahead of 1st-in-human trials early next year. The...
View ArticleClik here to view.
Private Equity firm EQT buys Lima
Lima Corporate said today private equity firm EQT acquired it through the purchase of the majority of the company’s shares, shifting ownership from Ardian. The transaction is still subject to...
View ArticleClik here to view.
Insightec touts reimbursement win for Exablate
Insightec said today it received positive coverage policies from Blue Cross Blue Shield licensees for its Exablate magnetic resonance imaging-guided focused ultrasound device for pain palliation...
View ArticleClik here to view.
CytoSorbents scraps EAP path, pursues IDE and PMA for CytoSorb
CytoSorbents (OTC:CTSO) said today it’s dropping its pursuit of the FDA’s fast-track Expedited Access Pathway for its CytoSorb for treating sepsis. The decision came after meeting with the FDA’sCenter...
View ArticleClik here to view.
MassDevice.com +3 | The top 3 medtech stories for December 23, 2015
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...
View ArticleClik here to view.
Seno Medical touts data from Imagio breast cancer pilot study
Seno Medical Instruments on Monday released data from the pilot study portion of its Pioneer pivotal study examining its Imagio opto-acoustic tool designed to diagnose breast cancer. The company said...
View ArticleClik here to view.
BionX adds $11.4m for powered ankle prosthetic
BionX said it added $11.4 million to the $6 million it drummed up last year for its Biom powered ankle prosthesis. BionX, previously known as BiOM (which was formerly known as iWalk), said in a...
View ArticleClik here to view.
Avedro CEO Muller is out | Personnel Moves
Avedro said CEO David Muller stepped down shortly after it closed a $32 million equity round last month, replaced on an interim basis by COO Brian Roberts, the former CFO at Insulet (NSDQ:PODD)....
View ArticleClik here to view.
Fed. Circ. upholds doc’s $4.3m IP win over Globus
The Federal Circuit Court on Wednesday upheld a doctor’s $4.3 million win over Globus Medical (NYSE:GMED) in a case examining supposed stolen trade secrets connected to 3 spinal fusion devices. A jury...
View ArticleClik here to view.
Avita Medical sheds respiratory biz for $2.64m
Avita Medical (ASX:AVH) said today it sold its respiratory business to Medical Developments International for $2.64 million. The division includes Avita’s Breath-A-Tech and Funhaler asthma spacers...
View ArticleClik here to view.
Pulse Biosciences registers for $20m IPO
Pulse Biosciences, which is developing pulsed electric field technology to treat solid tumors, last week filed for an initial public offering worth $20 million. Burlingame, Calif.-based Pulse said it...
View ArticleClik here to view.
Steris gains on post-Synergy merger outlook
Steris (NYSE:STE) shares are up nearly 8% since the company last week issued its 1st post-merger guidance since its $2 billion merger with the U.K.’s Synergy Health, as investors reacted to a top-line...
View ArticleClik here to view.
FDA clears Biotronik’s full-body MRI-safe Iperia ICDs
Biotronik said last week it won FDA premarket approval for its Iperia family of magnetic resonance imaging-compatible implantable cardioverter defibrillators. The approval includes Biotronik’s Iperia...
View ArticleClik here to view.
Hologic picks up DiagnoCure PCA3 prostate marker assets for $4.7m
DiagnoCure said last week it sold its PCA3 prostate cancer biomarker assets to Hologic‘s (NSDQ:HOLX) subsidiary Gen-Probe for $4.7 million (C$6.5 million). The purchase is slated to include $4 million...
View ArticleClik here to view.
MiMedx revives Organogenesis beef
MiMedx (NSDQ:MDXG) CEO Pete Petit last week renewed a beef with regenerative medicine rival Organogenesis, accusing that company of being behind a short-seller’s letter advising investors to bet...
View ArticleClik here to view.
FDA clears FujiFilm reprocessing label for ’superbug’-susceptible duodenoscopes
The FDA last week said it cleared Fujifilm Holdings‘ (TSE:4901) revised manual reprocessing instructions for its ED-530XT duodenoscope, replacing reprocessing instructions included on the original...
View Article